Raymond James Downgrades Dipexium Pharmaceuticals (DPRX) to Market Perform

October 26, 2016 7:33 AM EDT
Get Alerts DPRX Hot Sheet
Price: $1.58 +5.33%

Rating Summary:
    1 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade DPRX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Raymond James downgraded Dipexium Pharmaceuticals (NASDAQ: DPRX) from Outperform to Market Perform and removed its price target.

For an analyst ratings summary and ratings history on Dipexium Pharmaceuticals click here. For more ratings news on Dipexium Pharmaceuticals click here.

Shares of Dipexium Pharmaceuticals closed at $2.80 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Raymond James

Add Your Comment